A patient diagnosed with both HIV and leukemia has undergone a revolutionary gene therapy combined with a stem cell transplant. The most common treatment for leukemia is radiation and chemotherapy to eliminate the patient’s malfunctioning blood cells, which are created in the bone marrow. Following radiation and chemo, patients typically receive intravenous infusions of healthy blood stem cells to re-establish healthy bone marrow. However, the researchers took this treatment one step further by editing the new stem cells to disrupt the effect of a gene called CCR5, which the HIV virus typically uses to infect immune cells. In doing so, the doctors tackled both the patient’s leukemia and HIV in one revolutionary therapy.
In the two years since the treatment, the patient’s cancer is in complete remission, and the edited immune cells continue persist in his system and support the work of the anti-retroviral drugs that are used to keep the virus manageable. Though the HIV virus was not completely eradicated from the patient’s system, the encouraging results are leading to further exploration of gene therapy as a viable option for curing patients with HIV.
Advances in stem cell based regenerative treatments are creating more effective treatment options for patients suffering from a wide variety of disease, trauma and injury. To learn more about stem cells, and how families can bank their own valuable stem cells by recovering the very powerful dental pulp stem cells during routine dental procedures; such as wisdom teeth extractions or the during the loss of baby teeth, visit StemSave or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.